No Man

Sign in

Join Free
Post RFQ

Tofacitinib Citrate

TypeName: Business Offer

Category:

Country: United States

Summary: Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection.
https://www.bocsci.com/tofacitinib-citrate-cas-540737-29-9-item-461917.html

Description: [RequestDescription]

OfferId: 2394

Name:Alex Brown

Telphone:

Email:[email protected]